MedPath

The role of fat in symptom generation in patients with functional dyspepsia

Completed
Conditions
indigestion
Upper abdominal complaints
10017943
Registration Number
NL-OMON33884
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
25
Inclusion Criteria

18-65 years old
Recurrent bothersome postprandial fullness, early satiation and/or epigastric pain
At least 2 days per week for 3 months or more

Exclusion Criteria

Esophagitis
Barrett's esophagus
Peptic ulcer disease
Prior gastrointestinal surgery
Pregnancy
Drug- or alcohol abuse
Use of Aspirin in combination with Clopidogrel

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Differences in duodenal mRNA expression of genes, involved in the<br /><br>chylomicron-apoA-IV-CCK pathway, between FD patients and healthy controls.<br /><br><br /><br>Relationship between duodenal mRNA expression of genes, involved in the<br /><br>chylomicron-apoA-IV-CCK pathway, upon duodenal lipid load and sensitivity to<br /><br>gastric distension and/or gastric emptying rate of FD patients.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Differences in plasma and duodenal mucosal concentrations of apoA-IV and/or CCK<br /><br>between FD patients and healthy controls.<br /><br><br /><br>Relationship between plasma and duodenal mucosal concentrations of apoA-IV<br /><br>and/or CCK upon duodenal lipid load and sensitivity to gastric distension<br /><br>and/or gastric emptying rate of FD patients.</p><br>
© Copyright 2025. All Rights Reserved by MedPath